๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

9118 POSTER Prospective Assesment of Combined Pemetrexed and Erlotinib or Gefitinib Therapy After the Relapse to Erlotinib or Gefitinib in Patients With Advanced Non-Small Cell Lung Cancer Having an Active Epidermal Growth Factor Receptor Mutation

โœ Scribed by Okishio, K.; Yoshimura, N.; Kimura, T.; Daga, H.; Takeda, K.; Kawaguchi, T.; Kobayashi, M.; Hirashima, T.; Hirata, K.; Kudoh, S.

Book ID
121983992
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
55 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

9017 POSTER DISCUSSION Initial Detection
9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib
โœ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 43 KB